Spectrum Pharmaceuticals, Inc. Contracts & Agreements

Merger Agreement, dated as of April 24, 2023, by and among Spectrum Pharmaceuticals, Inc., Assertio Holdings Inc. and Spade Merger Sub 1, Inc. (Form of CVR Agreement included as... (Filed With SEC on April 25, 2023)

Form of NEO Stock Option Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on March 31, 2023)

Form of NEO Restricted Stock Unit Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on March 31, 2023)

Form of Non-NEO Stock Option Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on March 31, 2023)

Form of Non-NEO Restricted Stock Unit Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on March 31, 2023)

License, Development and Supply Agreement, dated as of October 8, 2014, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Filed With SEC on March 31, 2023)

First Amendment to License, Development and Supply Agreement, dated as of February 28, 2018, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Filed With SEC on March 31, 2023)

Second Amendment to License, Development and Supply Agreement, dated as of January 1, 2022, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Filed With SEC on March 31, 2023)

Supply Agreement, dated as of February 28, 2018, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Filed With SEC on March 31, 2023)

First Amendment to Supply Agreement, dated as of December 6, 2019, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Filed With SEC on March 31, 2023)

Second Amendment to Supply Agreement, dated as of January 1, 2022, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Filed With SEC on March 31, 2023)

Confidential Separation Agreement and General Release, dated December 31, 2022, between Spectrum Pharmaceuticals, Inc. and Francois Lebel (Filed With SEC on January 4, 2023)

Consulting Agreement, dated January 2, 2023, between Spectrum Pharmaceuticals, Inc. and Francois Lebel (Filed With SEC on January 4, 2023)

Form of Warrant (Filed With SEC on September 23, 2022)

Loan and Security Agreement, dated September 21, 2022, by and among Spectrum Pharmaceuticals, Inc., the other borrowers party thereto, the lenders party thereto and SLR Investment... (Filed With SEC on September 23, 2022)

Employment Agreement, dated May 25, 2022, by and between the Company and Nora Brennan (Filed With SEC on August 12, 2022)

Amended and Restated Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 23, 2022)

Description of Equity Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 18, 2022)

Securities Purchase Agreement, dated January 3, 2022, between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceutical Co., Ltd (Filed With SEC on January 6, 2022)

Description of Equity Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 31, 2021)

Underwriting Agreement by and between Spectrum Pharmaceuticals, Inc. and Jefferies LLC, dated July 29, 2020 (Filed With SEC on August 3, 2020)

First Amendment to the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 19, 2020)

Form of Stock Appreciation Rights Agreement under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on March 13, 2020)

Description of Equity Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 2, 2020)

Seventh Amendment to Lease, dated August 7, 2018, by and between Spectrum Pharmaceuticals, Inc. and the Irvine Company LLC (Filed With SEC on March 2, 2020)

Eighth Amendment to Lease, dated October 10, 2018, by and between Spectrum Pharmaceuticals, Inc. and the Irvine Company LLC (Filed With SEC on March 2, 2020)

Form of Indemnification Agreement of Spectrum Pharmaceuticals, Inc (Filed With SEC on March 2, 2020)

Amended and Restated Spectrum Pharmaceuticals, Inc. 2009 Employee Stock Purchase Plan (Filed With SEC on March 2, 2020)

Executive Employment Agreement, dated as of June 19, 2019, by and between Spectrum Pharmaceuticals, Inc. and Dr. Francois Lebel (Filed With SEC on August 9, 2019)

Asset Purchase Agreement, dated January 17, 2019, by and among Spectrum Pharmaceuticals, Inc., Acrotech Biopharma LLC and Aurobindo Pharma USA, Inc (Filed With SEC on January 17, 2019)

Amended and Restated Spectrum Pharmaceuticals, Inc. 2009 Employee Stock Purchase Plan (Filed With SEC on November 8, 2018)

Executive Employment Agreement, dated as of April 10, 2018, by and between Spectrum Pharmaceuticals, Inc. and Kurt A. Gustafson (Filed With SEC on August 9, 2018)

Executive Employment Agreement, dated as of April 10, 2018, by and between Spectrum Pharmaceuticals, Inc. and Thomas J. Riga (Filed With SEC on August 9, 2018)

Executive Employment Agreement, dated as of April 10, 2018, by and between Spectrum Pharmaceuticals, Inc. and Joseph W. Turgeon (Filed With SEC on August 9, 2018)

Executive Employment Agreement, dated as of June 18, 2018, by and between Spectrum Pharmaceuticals, Inc. and Keith McGahan (Filed With SEC on August 9, 2018)

Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 18, 2018)

Form of Stock Option Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 18, 2018)

Form of Restricted Stock Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 18, 2018)

Form of Canadian Restricted Stock Unit Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 18, 2018)

Form of Performance Unit Award under the Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Filed With SEC on June 18, 2018)

Second Amendment to Rights Agreement, dated March 27, 2018, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (Filed With SEC on March 29, 2018)

Sublicense Agreement, dated December 21, 2007, by and among Cell Therapeutics, Inc., Biogen Idec Inc., Corixa Corporation, Coulter Pharmaceutical, Inc., The Regents of the... (Filed With SEC on March 7, 2018)

First Amendment to Rights Agreement, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent, dated October 13, 2017 (Filed With SEC on October 13, 2017)

SPECTRUM PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) AT MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on August 4, 2017)

CONFIDENTIAL LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF JANUARY 23, 2012 BETWEEN SPECTRUM PHARMACEUTICALS CAYMAN, L.P. AND BAYER PHARMA AG (Filed With SEC on May 4, 2017)

SPECTRUM PHARMACEUTICALS, INC. 2009 INCENTIVE AWARD PLAN PERFORMANCE UNIT AWARD GRANT NOTICE (Filed With SEC on May 4, 2017)

LICENSE AGREEMENT (Filed With SEC on August 9, 2016)

AMENDMENT TO LICENSE AND ASSET PURCHASE AGREEMENT (Filed With SEC on May 6, 2016)

AMENDMENT NO. 1 TO CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 14, 2016)

CO-PROMOTION AGREEMENT (Filed With SEC on March 14, 2016)

LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF NOVEMBER 16, 2015 BETWEEN SPECTRUM PHARMACEUTICALS CAYMAN, L.P. AND MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED (Filed With SEC on March 14, 2016)

SPECTRUM PHARMACEUTICALS CAYMAN, L.P. and MUNDIPHARMA MEDICAL COMPANY SUPPLY AGREEMENT (Filed With SEC on March 14, 2016)

SPECTRUM PHARMACEUTICALS, INC. AMENDMENT NO. 1 TO 2003 AMENDED AND RESTATED INCENTIVE AWARD PLAN (Filed With SEC on November 6, 2015)

SPECTRUM PHARMACEUTICALS, INC. AMENDMENT NO. 1 TO 2009 INCENTIVE AWARD PLAN (Filed With SEC on November 6, 2015)

FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 7, 2015)

AMENDMENT NO. 2 TO CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 7, 2015)

Lease Agreement For 11500 S. Eastern Avenue, Suites 220, 240 & 270, Henderson, Nevada 89052 Between 11500 SouthEastern Avenue, LLC, a Nevada limited liability company Landlord and... (Filed With SEC on August 8, 2014)

FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2014)

CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 31, 2014)

REGISTRATION RIGHTS AND STOCKHOLDER AGREEMENT (Filed With SEC on March 12, 2014)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 12, 2014)

THIRD AMENDMENT TO LEASE (Filed With SEC on March 12, 2014)

FIFTH AMENDMENT TO LEASE (Filed With SEC on March 12, 2014)

SIXTH AMENDMENT TO LEASE (Filed With SEC on March 12, 2014)

SPECTRUM PHARMACEUTICALS, INC. AS ISSUER 2.75% CONVERTIBLESENIOR NOTES DUE 2018 INDENTURE DATED AS OF DECEMBER23, 2013 WILMINGTON TRUST, NATIONAL ASSOCIATION AS TRUSTEE TABLE OF... (Filed With SEC on December 23, 2013)

$100,000,000 SPECTRUMPHARMACEUTICALS, INC. 2.75% Convertible Senior Notes due 2018 PURCHASE AGREEMENT (Filed With SEC on December 23, 2013)

AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ALLOS THERAPEUTICS, INC., aDelaware corporation and MUNDIPHARMA INTERNATIONAL CORPORATION... (Filed With SEC on August 9, 2013)

ALLOS THERAPEUTICS, INC. and MUNDIPHARMA MEDICAL COMPANY AMENDED AND RESTATED SUPPLY AGREEMENT TABLE OF CONTENTS (Filed With SEC on August 9, 2013)

SECURITIES PURCHASE AGREEMENT by and among SPECTRUM PHARMACEUTICALS, INC. EAGLE ACQUISITION MERGER SUB, INC. and THE SECURITYHOLDERS OF TALON THERAPEUTICS, INC. NAMED HEREIN JULY... (Filed With SEC on July 19, 2013)

STOCK PURCHASE AGREEMENT by and among SPECTRUM PHARMACEUTICALS, INC., TALON THERAPEUTICS, INC. and EAGLE ACQUISITION MERGER SUB, INC. July 16, 2013 TABLE OF CONTENTS (Filed With SEC on July 19, 2013)

CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on July 19, 2013)

EXCHANGE AGREEMENT (Filed With SEC on July 19, 2013)

AMENDMENT NO. 1 TO CREDIT AGREEMENT (Filed With SEC on July 19, 2013)

LICENSE AGREEMENT (Filed With SEC on May 9, 2013)

SUPPLY AGREEMENT (Filed With SEC on May 9, 2013)

SECOND AMENDMENT TO SUBLEASE AGREEMENT (Filed With SEC on February 28, 2013)

SECOND AMENDMENT OF THE LICENSE, DEVELOPMENT, SUPPLY AND DISTRIBUTION AGREEMENT (Filed With SEC on February 28, 2013)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 28, 2013)

SPECTRUM PHARMACEUTICALS, INC. TERM SHEET FOR 2009 INCENTIVE AWARD PLAN NONQUALIFIED STOCK OPTION AWARD AWARDED TO NON-EMPLOYEE DIRECTORS (Filed With SEC on November 9, 2012)

LICENSE AGREEMENT (Filed With SEC on November 9, 2012)

LICENSE-BACK AGREEMENT (Filed With SEC on November 9, 2012)

SUBLICENSE AGREEMENT (Filed With SEC on November 9, 2012)

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT MARKED WITH [***] HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE... (Filed With SEC on November 9, 2012)

SUBLICENSE AGREEMENT (Filed With SEC on November 9, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2012)

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT MARKED WITH [***] HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO... (Filed With SEC on November 9, 2012)

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT MARKED WITH [***] HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE... (Filed With SEC on November 9, 2012)

LICENSE AGREEMENT (Filed With SEC on November 9, 2012)

MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 9, 2012)

CREDIT AGREEMENT Dated as of September 5, 2012 among SPECTRUM PHARMACEUTICALS, INC., as the Borrower, THE SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, BANK OF... (Filed With SEC on September 11, 2012)

CONFIDENTIAL LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF JANUARY 23, 2012 BETWEEN SPECTRUM PHARMACEUTICALS CAYMAN, L.P. AND BAYER PHARMA AG TABLE OF CONTENTS (Filed With SEC on April 27, 2012)

AGREEMENT AND PLAN OF MERGER among: SPECTRUM PHARMACEUTICALS, INC., a Delaware corporation; SAPPHIRE ACQUISITION SUB, INC., a Delaware corporation; and ALLOS THERAPEUTICS, INC., a... (Filed With SEC on April 5, 2012)

CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on April 5, 2012)

TENDER AND VOTING AGREEMENT (Filed With SEC on April 5, 2012)

FIRST AMENDMENT TO SUBLEASE AGREEMENT (Filed With SEC on March 2, 2012)

EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)

Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For... (Filed With SEC on March 10, 2011)

RIGHTS AGREEMENT between SPECTRUM PHARMACEUTICALS, INC., and COMPUTERSHARE TRUST COMPANY, N.A., as Rights Agent, Dated as of December 13, 2010 (Filed With SEC on December 13, 2010)

Maximizing the growth potential of our marketed drugs, Zevalin and Fusilev. Our near-term outlook largely depends on sales and marketing successes for our two marketed drugs. For... (Filed With SEC on April 5, 2010)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on September 23, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on September 23, 2009)

Exhibit Number (Filed With SEC on September 23, 2009)

Financial Statements (Filed With SEC on August 13, 2009)

SPECTRUM PHARMACEUTICALS, INC. 2003 AMENDED AND RESTATED INCENTIVE AWARD PLAN (Filed With SEC on July 2, 2009)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20thFloor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on July 2, 2009)

COMMON STOCK PURCHASE WARRANT SPECTRUM PHARMACEUTICALS, INC. Warrant Shares: Issue Date: July _____, 2009 Warrant Number: (Filed With SEC on July 2, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 2, 2009)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20thFloor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on June 18, 2009)

COMMON STOCK PURCHASE WARRANT SPECTRUM PHARMACEUTICALS, INC. Warrant Shares: Issue Date: June , 2009 Warrant Number: (Filed With SEC on June 18, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 18, 2009)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on May 28, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on May 28, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 28, 2009)

(In Thousands, Except Share and Per (Filed With SEC on May 15, 2009)

Exhibit Number (Filed With SEC on May 7, 2009)

Maximizing the growth potential for our marketed drugs, Fusilev and Zevalin. The companys near-term outlook depends on sales and marketing successes associated with our two... (Filed With SEC on March 31, 2009)

PURCHASE AND FORMATION AGREEMENT (Filed With SEC on December 19, 2008)

(In Thousands, Except Share and Per (Filed With SEC on August 11, 2008)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 26, 2008)

(In Thousands, Except Share and Per (Filed With SEC on November 9, 2007)

In Thousands, Except Share and Per Share Data (Filed With SEC on August 9, 2007)

Exhibit No (Filed With SEC on May 4, 2007)

Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked [* * *] and has been filed separately with the Securities and Exchange Commission pursuant... (Filed With SEC on March 14, 2007)

SECOND AMENDMENT TO LICENCE AGREEMENT (Filed With SEC on March 2, 2007)

AMENDMENTNO. 5 TOTHE RIGHTSAGREEMENT DATEDAS OF DECEMBER 13, 2000 BYAND BETWEEN SPECTRUMPHARMACEUTICALS, INC. AND U.S.STOCK TRANSFER CORPORATION (Filed With SEC on November 3, 2006)

Confidential treatmenthas been requested for portions of this Exhibit. The copy filed herewith omits the information subject to the confidentiality request.Omissions are... (Filed With SEC on November 3, 2006)

SPECTRUM PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED 1997 STOCK INCENTIVE PLAN (As Amended and Restated Effective as of September 26, 2006) (Filed With SEC on November 3, 2006)

LICENSE AGREEMENT (Filed With SEC on August 8, 2006)

MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 8, 2006)

FOURTH AMENDMENT TO THE RIGHTS AGREEMENT (Filed With SEC on July 12, 2006)

In Thousands, Except Share and Per Share Data (Filed With SEC on May 8, 2006)

Eight proprietary drug product candidates, or drug products with respect to which we have patent rights, either directly or through licensing, under development, including one in... (Filed With SEC on March 15, 2006)

In Thousands, Except Share and Per Share Data (Filed With SEC on November 4, 2005)

Description of Document (Filed With SEC on September 22, 2005)

Description of Document (Filed With SEC on September 15, 2005)

(In Thousands, Except Share and Per (Filed With SEC on August 9, 2005)

Description of Document (Filed With SEC on May 20, 2005)

In Thousands, Except Share and Per Share Data (Filed With SEC on May 10, 2005)

Description of Document (Filed With SEC on April 19, 2005)

Recapitalized the Company by securing over $55 million in equity financing (Filed With SEC on March 15, 2005)

Description of Document (Filed With SEC on February 25, 2005)

Description of Document (Filed With SEC on February 3, 2005)

Description of Document (Filed With SEC on December 17, 2004)

In Thousands, Except Share and Per Share Data (Filed With SEC on November 15, 2004)

Description of Document (Filed With SEC on November 8, 2004)

(In Thousands, Except Share and (Filed With SEC on August 16, 2004)

In Thousands, Except Share and Per Share Data (Filed With SEC on May 17, 2004)

Investor Rights Agreement dated as of April 20, 2004, by and among Spectrum and the persons listed on Schedule 1 attached thereto (Filed With SEC on April 23, 2004)

Drug Candidate (Filed With SEC on March 29, 2004)

FINANCIAL INFORMATION (Filed With SEC on November 13, 2003)

Registration Rights Agreement dated as of August 13, 2003, by and among Spectrum and the persons listed on Schedule 1 attached thereto (Filed With SEC on August 15, 2003)

FINANCIAL INFORMATION (Filed With SEC on August 14, 2003)

PART I. FINANCIAL INFORMATION (Filed With SEC on May 14, 2003)

Legal Proceedings (Filed With SEC on March 28, 2003)

WARRANT Dated: January 16, 2003 Number SPPIXXX (Filed With SEC on January 17, 2003)

EXHIBIT A EXHIBIT B SCHEDULE 1 Purchaser Shares Purchase Price Warrant Shares Cranshire Capital, LP 88,889 $200,000.25 22,222 Omicron Master Trust 88,889 $200,000.25 22,222 ICN... (Filed With SEC on January 17, 2003)

WARRANT Dated: December 13, 2002 Number SPPIXXX (Filed With SEC on December 23, 2002)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 23, 2002)

FINANCIAL INFORMATION (Filed With SEC on November 13, 2002)

CONFIDENTIAL RETIREMENT AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 23, 2002)

FINANCIAL INFORMATION (Filed With SEC on August 19, 2002)

Form of Warrant dated as of July 8, 2002 (Filed With SEC on July 12, 2002)

Form of Warrant dated as of June 7, 2002 (Filed With SEC on June 19, 2002)

Form of Warrant (Filed With SEC on June 7, 2002)

Letter Agreement, dated as of November 19, 2001, by and between NeoTherapeutics, Inc. and Ladenburg Thalmann & Co., Inc (Filed With SEC on December 11, 2001)

Amendment to Sales Agreement, dated as of October 19, 2001, by and between Registrant and Cantor Fitzgerald & Co (Filed With SEC on October 24, 2001)

Stock Purchase Agreement dated as of August 13, 2001, by and among the Registrant, NeoGene Technologies, Inc., Montrose Investments Ltd. and Strong River Investments, Inc (Filed With SEC on August 27, 2001)

Category

Industry

Companies

Contracts

Spectrum Pharmaceuticals, Inc. Contracts & Agreements